Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Similar documents
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Section 3, Lecture 2

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Cardiac Pathophysiology

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Hypertension (JNC-8)

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Antihypertensive drugs SUMMARY Made by: Lama Shatat

5.2 Key priorities for implementation

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Categories of HTN. Overview of Hypertension. Types of Hypertension

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Antihypertensives. Diagnostic category

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP

Management of Hypertension

LESSON ASSIGNMENT. After completing this lesson you will be able to:

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

Beta 1 Beta blockers A - Propranolol,

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Difficult to Treat Hypertension

What in the World is Functional Medicine?

sympatholytics sympatholytics sympatholytics

Hypertension. Penny Mosley MRPharmS

STANDARD treatment algorithm mmHg

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to

Top 200 Section 4. Cardiovascular Drugs

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

ANTI- HYPERTENSIVE AGENTS

Hypertension Management - Summary

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart Failure (HF) Treatment

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

M2 TEACHING UNDERSTANDING PHARMACOLOGY

Get Healthy Stay Healthy

Dr Doris M. W Kinuthia

Chapter 26. Media Directory. Dysrhythmias. Diagnosis/Treatment of Dysrhythmias. Frequency in Population Difficult to Predict

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide

HYPERTENSION. Shelby Bublitz Winter Quarter 2015 Cory Ruth NTRS 415A-03 Shelly Truong Professor Owen

Antihypertensive drugs: I. Thiazide and other diuretics:

major public health burden

COMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

High blood pressure (Hypertension)

Combination Therapy for Hypertension

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

Heart Failure Clinician Guide JANUARY 2018

Heart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN

Hypertension Clinical case scenarios for primary care

Cardiorenal and Renocardiac Syndrome

PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

Nursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) CANDESARTAN/HYDROCHLOROTHIAZIDE ORION 8 MG/12.5 MG, 16 MG/12.5 MG, 32 MG/12.5 MG, 32 MG/25 MG ORION

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

Antihypertensive Agents

TREATMENT OF HYPERTENSION

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

Management of High Blood Pressure in Adults

Genetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension.

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Blood Pressure Management in Acute Ischemic Stroke

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

CHF for Clinician. AtHomeCare.com

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Instruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy

Fundamentals of Pharmacology for Veterinary Technicians Chapter 8

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension. Hypertension, also referred to as high blood

1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril.

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment

Heart Failure Clinician Guide JANUARY 2016

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Policy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016

By Prof. Khaled El-Rabat

Treatment of Essential Hypertension

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.

Chapter 28. Media Directory. Hematopoiesis. Regulation of Hematopoiesis. Erythropoietin. Drugs for Hematopoietic Disorders

Hypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union

- Dr Alia Shatnawi. 1 P a g e

HTN of pregnancy is serious and must be controlled, because without monitoring it can develop into pre-eclampsia and finally to eclampsia.

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

PRODUCT CIRCULAR. Tablets COZAAR (losartan potassium) I. THERAPEUTIC CLASS II. INDICATIONS III. DOSAGE AND ADMINISTRATION PAK-CZR-T

What s In the New Hypertension Guidelines?

hypertension Head of prevention and control of CVD disease office Ministry of heath

From the desk of the: THE VIRTUAL NEPHROLOGIST

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Transcription:

Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes conditions of heart and blood vessels Hypertension is most common form of CVD Most frequent causes of death in U.S Prehypertension Stage 1 Stage 2 Hypertension: Classified into Three Categories Blood Pressure Changes throughout Lifespan Normal B/P at one age; abnormal as we age Heart Brain Kidneys Retina Target Organs Affected by Untreated Hypertension 1

Disease Progression Related to Organs Heart failure TIA and/or cerebral vascular accident Renal failure Visual impairment and blindness Cardiac Output Determined by Stroke volume Heart rate Medications that affect cardiac output, stroke volume, heart rate influence blood pressure Peripheral Resistance Blood Volume Friction in arteries as blood flows through vascular system Greater resistance in arteries yields higher blood pressure Medications that affect vascular smooth muscles may lower or raise B/P Autonomic nervous system plays role in controlling peripheral resistance Total amount of blood in vascular system Increased blood volume increases blood pressure Medications that affect blood volume may lower or raise B/P Central and Autonomic Nervous Systems Figure 23.3 Hormonal and nervous factors influencing blood pressure. Regulate blood pressure Vasomotor center Baroreceptors Chemoreceptors 2

Emotions Affect Blood Pressure Endocrine System Stress and anger increase Depression and lethargy decrease Regulates blood pressure Natural hormones affect blood pressure daily Epinephrine and norepinephrine injections raise B/P Antidiuretic hormone raises B/P by raising blood volume Assessment of Client s Lifestyle Dietary habits Exercise or activity regimen Use of medication Genetic Factors That May Contribute to Client s Hypertension Risk Race Gender Family history of hypertension Environmental Factors That May Contribute to Client s Hypertension Role Tobacco use, high-fat diets, obesity Excessive sodium intake or alcohol consumption Sedentary lifestyle Factors That Can Help Control Blood Pressure Losing weight Limiting foods high in fat and sodium Limiting use of tobacco and alcohol Beginning an exercise program 3

Primary Antihypertensive Agents Diuretics Angiotensin-converting enzyme (ACE) inhibitors Angiotensin II receptor blockers Beta-adrenergic antagonists Calcium channel blockers Secondary Antihypertensive Agents Alpha1-adrenergic antagonist Alpha2-adrenergic agonists Direct-acting vasodilators Role of Nurse Obtain complete health history Obtain vital signs Do physical examination Obtain blood and urine specimens for analysis for Nonpotassium-Sparing Diuretics Orthostatic hypotension Laboratory electrolyte values, especially potassium level, and daily weights Intake and output assessment of edema and signs of fluid overload Client s ability to safely ambulate Photosensitivity Possible need to increase potassium in diet or with supplements for Potassium-Sparing Diuretics Use of salt substitutes and potassium-rich foods Use in pregnant and lactating women History of gout and kidney stones Uric-acid levels Gynecomastia and hirsutism for spironolactone (Aldactone) Points for Thiazide-like Diuretics Laboratory values (CBC, electrolytes, chemistry panel) Blood-glucose and uric-acid levels Possible need to increase potassium in diet or with supplements Pregnancy and lactation, systemic lupus erythematosus, and use of digoxin 4

Points for Loop Diuretics Severe potassium loss Hypovolemia Hypotension Hearing loss (these drugs are ototoxic) Glucose and uric-acid levels Points for CCBs (continued) Obtain ECG, heart rate, and B/P prior to therapy During therapy, monitor heart rate and B/P regularly Health history specific for heart dysrhythmias and pregnancy Signs of CHF and reflex tachycardia Points for CCBs (continued) IV administration, special concern Dizziness, headache, flushing are minor side effects Avoid drinking grapefruit juice Points for Renin-Angiotensins Baseline vital signs Hypotension Angioedema Neutropenia or agranulocytosis for Renin-Angiotensins (continued) Hypokalemia Dizziness, light-headedness, headache Tickling, nonproductive cough Pregnancy-risk category D for Adrenergic Antagonists Baseline vital signs, B/P response Hold medication for pulse below 60 and B/P below 90/60 mm/hg ECG, heart rate and rhythm Watch for heart block and rebound hypertension 5

for Adrenergic Antagonists (continued) Routine blood-glucose monitoring for diabetics Alpha1, alpha2, and beta-blocker specific effects Pregnancy-risk categories B and C Points for Direct Vasodilators In emergency: monitor V/S, ECG, and pulse oximetry continuously Contraindicated for Hypersensitivity, coronary artery disease Rheumatic mitral-valve disease, cerebrovascular disease Renal insufficiency, systemic lupus erythematosus for Direct Vasodilators (continued) Priapism IV diazoxide (Hyperstat): monitor sodium and water output Minoxidil (Loniten): monitor for orthohypotension] for Direct Vasodilators (continued) Nitroprusside IV Only mix with 5% dextrose in water Drug extremely light sensitive, only stable for 24 hours Can be used for hypertensive emergencies during labor and delivery Diuretics Calcium Channel Blockers Prototype drug: hydrochlorothiazide (HydroDiuril). Mechanism of action: to increase amount of urine produced and excreted Primary use: for mild to moderate hypertension Adverse effects: electrolyte imbalances, especially loss of potassium Prototype drug: nifedipine (Procardia) Mechanism of action: to cause vasodilation, decreasing B/P Primary use: for hypertension and angina Adverse effects: include dizziness, headache, flushing 6

Nifedipine Animation Drugs Affecting Renin-Angiotensin System Angiotensin-converting enzyme (ACE) inhibitors Prototype drug: enalapril (Vasotec) Mechanism of action: to decrease blood volume Primary use: for hypertension Adverse effects: persistent cough and hypotension Click here to view an animation on the topic of doxazosin. Back to Directory Drugs Affecting Renin-Angiotensin System Angiotensin-receptor blockers (ARBs) Prototype drug: losartan potassium (Cozaar) Mechanism of action: to block angiotensin receptors in arterial smooth muscle and adrenal glands Primary use: for hypertension Adverse effect: hypotension Adrenergic Antagonists Prototype drug: doxazosin (Cardura) Mechanism of action: to block affects of the sympathetic nervous system leading to vasodilation Primary use: hypertension Adverse effects: orthostatic hypotension, dizziness, nausea, bradycardia, dry mouth Doxazosin Animation Direct Vasodilators Prototype drug: hydralazine (Apresoline) Mechanism of action: to cause vasodilation by direct relaxation of arterial smooth muscle Primary use: for severe hypertension and hypertension crisis Adverse effects: reflex tachycardia, sodium and fluid retention Click here to view an animation on the topic of doxazosin. Back to Directory 7

Drugs Assessment Take client s B/P in each arm for baseline Assess client s height and weight Obtain blood and urine samples as ordered by physician Obtain nursing history, including lifestyle, current medications, dietary habits Assess client s and family s knowledge of hypertension and medication regimen Drugs (continued) Nursing Diagnoses Decreased cardiac output related to excessive or prolonged systemic vascular resistance Knowledge deficit regarding condition, therapeutic regimen, and potential side effects of medications Ineffective therapeutic-regimen management related to complexity of therapy and cost of medications Risk for sexual dysfunction related to side effects of medications Drugs (continued) Planning Goals Exhibit a reduction in systolic/diastolic blood pressure Client is able to explain hypertension and needed medications Client is able to verbalize ability to follow prescribed therapy Drugs (continued) Implementation Encourage compliance Provide education regarding medication regimen Drugs (continued) Evaluation Ideal outcome criteria Lowered B/P with limited side effects Client able to verbalize importance of taking prescribed medications Diuretics Table 23.4 Diuretics 8

Calcium Channel Blockers ACE Inhibitors and Angiotensin II Receptor Blockers Table 23.5 Calcium Channel Blockers Table 23.6 ACE Inhibitors and Angiotensin II Receptor Blockers Adrenergic Antagonists Adrenergic Antagonists Table 23.7 Adrenergic Antagonists Table 23.7b Adrenergic Antagonists Direct-acting Vasodilators Table 23.8 Direct-acting Vasodilators 9